Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems director Geoffrey Scott Gates reported updated holdings of the company’s Common Stock. The Form 4 shows an indirect disposition of 10,000 shares coded as a tax-withholding transaction, leaving 40,686 shares held indirectly through a trust and 50,000 shares held indirectly by his spouse.
Following these entries, Gates also reports 52,864 shares held directly. A footnote states that the 10,000 shares were donated to a Charitable Gift Fund and that the reported amounts include shares subject to unvested restricted stock units, so part of his position is still vesting over time.
AEHR TEST SYSTEMS executive Alistair N. Sporck reported routine equity activity involving company stock. The filing shows that 133 shares of common stock at $88.48 per share were withheld to cover tax obligations when restricted stock units vested, which the company notes does not represent a sale by Sporck. After this tax withholding, he directly holds 20,161 shares of common stock and indirectly holds 5,177 shares through a trust, and the indirect amount includes shares subject to unvested restricted stock units. The transactions reflect compensation and tax mechanics rather than open-market trading.
AEHR Test Systems executive Vernon Rogers reported a routine tax-related share disposition. On this Form 4, 139 shares of Common Stock were withheld at $88.48 per share to cover tax obligations when restricted stock units vested. The filing notes this was not an open-market sale. After this withholding, Rogers directly held 147,577 shares, which the filing states includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS CTO Donald P. Richmond II reported a small tax-related share disposition. On this Form 4, 102 shares of common stock were withheld at $88.48 per share to cover tax obligations upon vesting of restricted stock units. The footnote clarifies this was not an open-market sale. After this withholding, he directly holds 181,410 shares, including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS President and CEO Gayn Erickson had 851 shares of common stock withheld at $88.48 per share to cover tax obligations when restricted stock units vested. This was a tax-withholding event, not an open-market sale.
After this transaction, Erickson holds 184,660 shares directly. An additional 197,723 shares are held indirectly by a trust, and this indirect amount includes shares subject to unvested restricted stock units and unvested restricted shares.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a routine tax-related share disposition. On the vesting of restricted stock units, 143 shares of common stock were withheld at $88.48 per share to satisfy tax withholding obligations. This was not an open-market sale. Following the withholding, Engineer holds 40,912 shares directly, and this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems director Rhea J. Posedel reported open-market sales of company stock. On April 22, 2026, a trust associated with Posedel sold 604 shares of Aehr Test Systems common stock at $95.00 per share, reported as indirect ownership.
On the same date, Posedel directly sold an additional 17,115 shares at $100.00 per share. After these transactions, filings show 396,375 shares held indirectly by a trust and 45,261 shares held directly, with the indirect amount including shares subject to unvested restricted stock units. Overall, the activity reflects a partial reduction rather than an exit.
AEHR Test Systems executive Alistair N. Sporck, VP Contactor Business Unit, reported an indirect open‑market sale of 2,000 shares of common stock at $93.495 per share through a trust. After this transaction, the trust holds 5,177 shares indirectly. Sporck also reports 20,294 shares held directly, and this direct amount includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS EVP Alberto Salamone reported two open-market sales of common stock. He sold 15,000 shares at $94.56 on April 21, 2026 and 15,000 shares at $89.57 on April 20, 2026, totaling 30,000 shares sold.
After these sales, he directly holds 48,025 shares of AEHR common stock. A footnote states this amount includes shares subject to unvested restricted stock units, meaning part of his reported holdings are still vesting over time.
Aehr Test Systems director Howard T. Slayen reported a charitable stock gift. He transferred 1,800 shares of Common Stock as a bona fide gift at a stated price of $0.00 per share. The shares were donated to a Donor Advised Charitable Giving Fund.
After the gift, Slayen directly owns 176,528 shares of Aehr Test Systems common stock, and this amount includes shares subject to unvested restricted stock units. The filing shows no option exercises or open-market stock purchases or sales, only this charitable transfer.